BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.620
-0.080 (-4.71%)
Jul 26, 2024, 4:00 PM EDT - Market closed
BioAtla Market Cap
BioAtla has a market cap or net worth of $77.95 million as of July 26, 2024. Its market cap has decreased by -44.36% in one year.
Market Cap
77.95M
Enterprise Value
-758.24K
1-Year Change
-44.36%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $77.95M, a decrease of -86.50%. That is a compound annual growth rate of -42.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 81.80M | -30.62% |
| Dec 29, 2023 | 117.90M | -62.00% |
| Dec 30, 2022 | 310.30M | -57.09% |
| Dec 31, 2021 | 723.10M | -31.39% |
| Dec 31, 2020 | 1.05B | 82.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 85.05M |
| PMV Pharmaceuticals | 83.85M |
| Cellectar Biosciences | 83.71M |
| Hyperfine | 83.53M |
| Instil Bio | 83.19M |
| Genenta Science | 81.98M |
| Boundless Bio | 80.78M |
| Leap Therapeutics | 80.74M |